pirodavir has been researched along with Common Cold in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, SY; Gong, ZH; Li, S; Mi, CL; Yan, H; Zheng, ZB; Zhou, XB | 1 |
| Aguayo, E; Birkus, G; Cihlar, T; Jordan, R; Lee, G; Mello, C; Rodriguez, M | 1 |
| Andries, K; Eisen, GF; Hayden, FG; Hipskind, GJ; Janssen, PA; Janssens, M; Woerner, DH | 1 |
| Andries, K; Hayden, FG; Janssen, PA | 1 |
2 trial(s) available for pirodavir and Common Cold
| Article | Year |
|---|---|
Intranasal pirodavir (R77,975) treatment of rhinovirus colds.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Antiviral Agents; Common Cold; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Piperidines; Pyridazines; Rhinovirus | 1995 |
Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.
Topics: Administration, Intranasal; Adolescent; Adult; Common Cold; Double-Blind Method; Humans; Middle Aged; Piperidines; Pyridazines | 1992 |
2 other study(ies) available for pirodavir and Common Cold
| Article | Year |
|---|---|
Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
Topics: Antiviral Agents; Capsid Proteins; Common Cold; Humans; Pyridazines; Rhinovirus; Structure-Activity Relationship | 2009 |
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Topics: Antiviral Agents; Common Cold; Dose-Response Relationship, Drug; HeLa Cells; Humans; In Vitro Techniques; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Piperidines; Pyridazines; Pyrrolidinones; Replicon; Rhinovirus; RNA, Viral; Tubercidin; Valine; Virus Replication | 2014 |